Insider Transactions in Q2 2021 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
130
+11.8%
|
-
|
|
Jun 30
2021
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
211
+10.24%
|
-
|
|
Jun 30
2021
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+50.0%
|
-
|
|
Jun 30
2021
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
195
+0.54%
|
-
|
|
Jun 30
2021
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.23%
|
-
|
|
Jun 30
2021
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
130
+0.0%
|
-
|
|
Jun 02
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
941
-0.8%
|
$74,339
$79.15 P/Share
|
|
Jun 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,245
-28.94%
|
$98,355
$79.15 P/Share
|
|
Jun 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-0.81%
|
$75,761
$79.99 P/Share
|
|
Jun 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Jun 01
2021
|
Julie Hambleton |
SELL
Open market or private sale
|
Direct |
2,000
-40.0%
|
$160,000
$80.0 P/Share
|
|
Jun 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,255
-22.58%
|
$99,145
$79.99 P/Share
|
|
Jun 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+31.03%
|
$0
$0.93 P/Share
|
|
May 26
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
444
-0.38%
|
$31,080
$70.0 P/Share
|
|
May 14
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-0.39%
|
$31,008
$68.76 P/Share
|
|
May 14
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+0.76%
|
$900
$1.39 P/Share
|
|
May 14
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
288
+8.61%
|
$12,960
$45.9 P/Share
|
|
May 14
2021
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
313
+15.55%
|
$14,085
$45.9 P/Share
|
|
May 14
2021
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
45
+0.8%
|
$2,025
$45.9 P/Share
|
|
May 05
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
469
-0.4%
|
$29,078
$62.32 P/Share
|
|
May 05
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,243
-30.98%
|
$77,066
$62.5 P/Share
|
|
May 03
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
481
-0.41%
|
$32,708
$68.03 P/Share
|
|
May 03
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
950
+0.8%
|
$950
$1.39 P/Share
|
|
May 03
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-23.86%
|
$85,476
$68.03 P/Share
|
|
May 03
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+32.18%
|
$0
$0.93 P/Share
|
|
Apr 12
2021
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
300
+2.31%
|
-
|
|
Apr 12
2021
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
300
-100.0%
|
-
|
|
Apr 06
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,222
-1.04%
|
$100,204
$82.0 P/Share
|
|
Apr 06
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,254
-31.17%
|
$102,828
$82.0 P/Share
|
|
Apr 05
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
678
-0.57%
|
$56,274
$83.4 P/Share
|
|
Apr 05
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Apr 05
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-23.65%
|
$103,418
$83.4 P/Share
|
|
Apr 05
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+32.18%
|
$0
$0.93 P/Share
|